Rosuvastatin NDC 16729-284

Product information

Brand name (proprietary)

Rosuvastatin

Generic name (nonproprietary)

rosuvastatin

Active ingredients

Rosuvastatin calcium — 5 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Accord Healthcare Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 206434

Marketing start

Oct 31, 2016

Listing expires

Dec 31, 2026

Other FDA classes

Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)

Identifiers

Product ID 16729-284_4390ed19-e509-95ab-e063-6294a90a2b08SPL ID 4390ed19-e509-95ab-e063-6294a90a2b08SPL set ID 3ffe0294-3997-2755-e054-00144ff8d46cRxCUI 859419, 859424, 859747, 859751UNII 83MVU38M7Q

Pharmacologic class

HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416729028415 followed by a unit qualifier and the quantity Copy

Package 16729-0284-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 206434

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.